Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

We're Not Afraid of This Biotech "Rout"

I happened to be on the phone with Michael Robinson, our resident tech-investing expert, yesterday when the conversation turned to the biotech sector.

We both like the sector's long-term upside: With the aging U.S. population, the demographic catalyst of the American market alone is a great reason to have a bullish long-term view of bioscience stocks.

And now the sector seems to be rebounding from its recent swoon - meaning there's reason to be bullish in the near-term, too...

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK